| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | STANDARD BIOTOOLS INC. | FLDM | Grant | Common Stock | 26.4k | $0.00 | $0 | | 06/14/2023 |
| 06/14/2023 | STANDARD BIOTOOLS INC. | FLDM | Grant | Stock Option (Right to Buy) | 35.4k | $2.18 | $77.1k | | 06/14/2023 |
| 06/15/2022 | STANDARD BIOTOOLS INC. | FLDM | Grant | Common Stock | 30.9k | $0.00 | $0 | | 06/15/2022 |
| 06/15/2022 | STANDARD BIOTOOLS INC. | FLDM | Grant | Stock Option (Right to Buy) | 42.6k | $1.86 | $79.2k | | 06/15/2022 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1.4k | $21.51 | $29.6k | | 05/10/2022 |
| 05/10/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 825 | $21.51 | $17.7k | | 05/10/2022 |
| 04/27/2022 | Genasys Inc. | LRAD | Exercise | Stock Option | 50k | $1.33 | $66.5k | | 04/27/2022 |
| 03/15/2022 | Genasys Inc. | LRAD | Grant | Common Stock | 30k | $0.00 | $0 | | 03/15/2022 |
| 02/23/2022 | Genasys Inc. | LRAD | Sale | Common Stock | 13.7k | $3.14 | $43.1k | | 02/23/2022 |
| 02/23/2022 | Genasys Inc. | LRAD | Exercise | Stock Option | 20k | $2.16 | $43.2k | | 02/23/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1.2k | $27.40 | $33.9k | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 39.4k | $27.50 | $1.1M | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Performance-based restricted stock units | 9.8k | $0.00 | $0 | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Performance-based restricted stock units | 8k | $0.00 | $0 | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 9.8k | $0.00 | $0 | | 01/31/2022 |
| 01/24/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 2.1k | $24.98 | $51.5k | | 01/24/2022 |
| 01/11/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 7.5k | $27.40 | $205.5k | | 01/10/2022 |
| 01/10/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 7.5k | $0.00 | $0 | | 01/10/2022 |
| 05/25/2021 | STANDARD BIOTOOLS INC. | FLDM | Grant | Common Stock | 10.3k | $0.00 | $0 | | 05/25/2021 |
| 05/25/2021 | STANDARD BIOTOOLS INC. | FLDM | Grant | Stock Option (Right to Buy) | 15.4k | $5.56 | $85.6k | | 05/25/2021 |
| 03/16/2021 | Genasys Inc. | LRAD | Grant | Common Stock | 27.9k | $0.00 | $0 | | 03/16/2021 |
| 03/10/2021 | Genasys Inc. | LRAD | Exercise | Stock Option | 20k | $2.02 | $40.4k | | 03/10/2021 |
| 03/10/2021 | Genasys Inc. | LRAD | Sale | Common Stock | 5.5k | $7.42 | $40.5k | | 03/10/2021 |
| 02/20/2021 | STANDARD BIOTOOLS INC. | FLDM | Grant | Common Stock | 9.8k | $0.00 | $0 | | 02/20/2021 |
| 02/08/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 2.2k | $31.58 | $71.1k | | 02/05/2021 |
| 02/05/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 2.2k | $31.41 | $70.7k | | 02/05/2021 |
| 02/03/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 2.5k | $28.91 | $72.3k | | 02/03/2021 |
| 02/03/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1.1k | $28.91 | $32.5k | | 02/03/2021 |
| 02/03/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 4.5k | $0.00 | $0 | | 02/03/2021 |
| 02/02/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 2.5k | $30.75 | $76.9k | | 01/31/2021 |
| 02/02/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1.1k | $30.75 | $34.6k | | 01/31/2021 |
| 01/31/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 5k | $0.00 | $0 | | 01/31/2021 |
| 01/21/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 15k | $0.00 | $0 | | 01/21/2021 |
| 01/21/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 57.5k | $26.88 | $1.5M | | 01/21/2021 |
| 11/25/2020 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 3.8k | $22.72 | $85.2k | | 11/23/2020 |
|